Company
INFItech Limited (INFItech) was founded by a university research team specializing in brain neuroscience. Our core technology, licensed from The Hong Kong University of Science and Technology (HKUST) in 2018, is based on the discovery of a series of proprietary Chinese medicine extracts and compounds with proven neuroprotective and neuro-regenerative properties.
This discovery is the result of over two decades of extensive research, validated through advanced in vitro and in vivo models. INFItech is now translating these breakthroughs into a robust pipeline of therapeutic candidates, with lead programs for neurodegenerative disorders advancing through preclinical and clinical development.
In parallel, and in direct response to pressing market needs, we have launched the Cogniherbs® series. These supplements leverage our core technology to deliver scientifically-formulated natural support for cognitive health and resilience, making the benefits of our discovery accessible today.
Description
INFItech Limited is a startup dedicated to developing innovative nutraceutical products for neurodegenerative diseases. Built on over 20 years of neuroscience research and development, the company integrates advanced scientific discoveries with Traditional Chinese Medicine (TCM) to create novel therapeutic solutions, to address the growing global demand for neurodegenerative disease treatments.
